Substance P (SP), calcitonin gene-related peptide (CGRP), and angiotensin converting enzyme (ACE) may have roles in trigeminovascular nociceptive mechanisms. We investigated interictal levels of SP, CGRP, ACE activity, and their correlation, in a sample of migraineurs. Forty-one patients suffering from migraine with aura (MA), 54 without aura (MO), and 52 non-headache subjects (controls) participated in this study. Blood samples were collected from cubital veins. Plasma levels of SP and CGRP were measured by enzyme immunoassay. Plasma ACE activities were measured spectrophotometrically. SP levels in MA (6.6 ± 3.7 pg/ml; mean ± SD) and MO (6.6 ± 3.2 pg/ml) were significantly higher than in controls (4.8 ± 2.4 pg/ml) (P < 0.01). CGRP levels in MA (18.8 ± 8.8 pg/ml) and MO (19.1 ± 9.4 pg/ml) were also significantly higher than in controls (13.4 ± 4.4 pg/ml) (P < 0.01).
Introduction
Migraine is a common disabling disease. In spite of considerable research on the mechanisms of migraine, details of its pathogenesis remain unclear. Among some theories, the trigeminovascular theory that Moskowitz proposed first in 1984 (Moskowitz, 1984 is widely accepted today. The hypothesis is that unknown triggers for headache activate perivascular trigeminal axons, which release vasoactive neuropeptides, such as substance P (SP), calcitonin gene-related peptide (CGRP), and neurokinin A, to promote neurogenic inflammation (vasodilation, plasma extravasation, mast cell degranulation) and spread the inflammatory response to adjacent tissues, and that orthodromic conduction along trigeminovascular fibers transmits nociceptive information toward the trigeminal nucleus caudalis and higher brain centers for the registration of pain (Moskowitz, 1992; Goadsby et al., 2002) .
There have been only a few studies of plasma SP and CGRP levels in adult patients with migraine headache, and these have provided contradictory results. Goadsby et al. (1990) reported that plasma CGRP level increased in both MA and MO, but that SP level did not change. On the other hand, Tvedskov et al. (2005) found no difference in CGRP levels during and outside of attacks. It must be pointed out that Goadsby et al. compared levels of the neuropeptides during migraine attacks with those of non-migraine controls and that Tvedskov et al. compared ictal and interictal levels in the same patients. 
